Biomarkers of sepsis
Cui Pin
Abstract
Cui Pin
Abstract
Sepsis,the leading cause of death in critically ill patients,is a systemic inflammatory response syndrome caused by pathogens,which could further develop into severe sepsis or septic shock. Early recognition,timely diagnosis,effective prevention and treatment are critical to improve the outcome of sepsis. Biomarkers play a significant role in the prognosis and diagnosis of sepsis. While none of these biomarkers have sufficient specificity or sensitivity to be employed in clinical practice. Biomarkers based on the abnormal inflammatory response and immunosuppression,combining with epigenetic markers,single nucleotide polymorphism and gene duplication of PIRO Stratification System will provide scientific basis for early alert,diagnosis and treatment of sepsis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sepsis,the leading cause of death in critically ill patients,is a systemic inflammatory response syndrome caused by pathogens,which could further develop into severe sepsis or septic shock. Early recognition,timely diagnosis,effective prevention and treatment are critical to improve the outcome of sepsis. Biomarkers play a significant role in the prognosis and diagnosis of sepsis. While none of these biomarkers have sufficient specificity or sensitivity to be employed in clinical practice. Biomarkers based on the abnormal inflammatory response and immunosuppression,combining with epigenetic markers,single nucleotide polymorphism and gene duplication of PIRO Stratification System will provide scientific basis for early alert,diagnosis and treatment of sepsis.
Key concepts: Sepsis, Medicine, Immunosuppression, Septic shock, Systemic inflammatory response syndrome, Intensive care medicine, Procalcitonin, Inflammatory response